We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19.
- Authors
Vilca-Alosilla, Juan Jeferson; Candia-Puma, Mayron Antonio; Coronel-Monje, Katiusca; Goyzueta-Mamani, Luis Daniel; Galdino, Alexsandro Sobreira; Machado-de-Ávila, Ricardo Andrez; Giunchetti, Rodolfo Cordeiro; Ferraz Coelho, Eduardo Antonio; Chávez-Fumagalli, Miguel Angel
- Abstract
In this paper, we present a systematic review and meta-analysis that aims to evaluate the reliability of coronavirus disease diagnostic tests in 2019 (COVID-19). This article seeks to describe the scientific discoveries made because of diagnostic tests conducted in recent years during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Between 2020 and 2021, searches for published papers on the COVID-19 diagnostic were made in the PubMed database. Ninety-nine scientific articles that satisfied the requirements were analyzed and included in the meta-analysis, and the specificity and sensitivity of the diagnostic accuracy were assessed. When compared to serological tests such as the enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), lateral flow immunoassay (LFIA), and chemiluminescent microparticle immunoassay (CMIA), molecular tests such as reverse transcription polymerase chain reaction (RT-PCR), reverse transcription loop-mediated isothermal amplification (RT-LAMP), and clustered regularly interspaced short palindromic repeats (CRISPR) performed better in terms of sensitivity and specificity. Additionally, the area under the curve restricted to the false-positive rates (AUCFPR) of 0.984 obtained by the antiviral neutralization bioassay (ANB) diagnostic test revealed significant potential for the identification of COVID-19. It has been established that the various diagnostic tests have been effectively adapted for the detection of SARS-CoV-2; nevertheless, their performance still must be enhanced to contain potential COVID-19 outbreaks, which will also help contain potential infectious agent outbreaks in the future.
- Subjects
SARS-CoV-2; COVID-19 testing; REVERSE transcriptase polymerase chain reaction; ENZYME-linked immunosorbent assay; COVID-19
- Publication
Diagnostics (2075-4418), 2023, Vol 13, Issue 9, p1549
- ISSN
2075-4418
- Publication type
Article
- DOI
10.3390/diagnostics13091549